Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure

R. K. Garg, M. Gheorghiade, S. M. Jafri*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Thromboembolism is an important complication in patients with heart failure. Several recent clinical trials have established the efficacy of anticoagulant therapy in patients with heart failure and atrial fibrillation. There is renewed interest in examining the role of antiplatelet and anticoagulation therapy in patients with heart failure in sinus rhythm. There is a need to identify patients at risk for thromboembolism in heart failure. However, there are data to suggest that occult thromboembolic events may contribute to disease progression, ischemic events, and sudden cardiac death. This review summarizes the incidence, potential mechanism, and therapeutic approaches for management of thromboembolism in heart failure.

Original languageEnglish (US)
Pages (from-to)225-236
Number of pages12
JournalProgress in Cardiovascular Diseases
Volume41
Issue number3
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure'. Together they form a unique fingerprint.

Cite this